DMAP analysis showed a comparatively higher expression of EHMT2 during CD4+/CD8+ T-cell lineage hematopoietic commitment (Supplementary Fig. 1F) and supports the hypothesis of a preferential cancer dependency based on hematopoietic lineage commitment. The gene discussed is EHMT2; the disease is cancer.